IASO
Live / Applied — Extension of time to oppose received (as of 16 Oct 2025)
What this means for you
Not registered yet, but its 01 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79412638
- Mark type
- Design + words
- Filed
- 01 Nov 2024
- Published for opposition
- 07 Oct 2025
- Attorney of record
- Yue Robert Xu
Goods and services
- Class 005 — Pharmaceuticals: Medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for use in chemotherapy; tumor suppressing agents; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; biological preparations for the treatment of tumor; biological preparations for medical purposes, for the treatment of tumor, endocrine, metabolic, central nervous system disorders, autoimmune disorders and blood disorders; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biochemical preparations for medical purposes, for the treatment of tumor, endocrine, metabolic, central nervous system disorders, autoimmune disorders and blood disorders; reagents for use in medical genetic testing; pharmaceutical products for the prevention and treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; medical diagnostic reagents; anti-cancer preparations; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; cytostatics for medical purposes; cells for medical use; antivirals; pharmaceutical preparations for the treatment of immune system related diseases and disorders; yeast extracts for medical, veterinary or pharmaceutical purposes
Owner
Prosecution history
- 16 Oct 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 07 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Oct 2025 — PUBLISHED FOR OPPOSITION
- 01 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Jul 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Jul 2025 — REFUSAL PROCESSED BY IB
- 17 Jun 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 17 Jun 2025 — REFUSAL PROCESSED BY MPU
- 16 Apr 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 15 Apr 2025 — NON-FINAL ACTION WRITTEN
- 27 Mar 2025 — ASSIGNED TO EXAMINER
- 03 Jan 2025 — APPLICATION FILING RECEIPT MAILED